These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15633256)

  • 1. Tenofovir and renal toxicity.
    AIDS Patient Care STDS; 2004 Oct; 18(10):615-6. PubMed ID: 15633256
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in chronic renal impairment following the discontinuation of tenofovir in two HIV-infected patients.
    Gracey D; Post J; MacLeod C; McKenzie P
    Nephrology (Carlton); 2011 May; 16(4):453-5. PubMed ID: 21518120
    [No Abstract]   [Full Text] [Related]  

  • 3. Tenofovir and changes in renal function.
    Gupta SK
    Clin Infect Dis; 2005 Aug; 41(4):570-1; author reply 571. PubMed ID: 16028175
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal safety of tenofovir disoproxil fumarate.
    Sax PE; Gallant JE; Klotman PE
    AIDS Read; 2007 Feb; 17(2):90-2, 99-104, C3. PubMed ID: 17323508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
    Gallant JE; Parish MA; Keruly JC; Moore RD
    Clin Infect Dis; 2005 Apr; 40(8):1194-8. PubMed ID: 15791522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
    Gupta Samir K
    AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure.
    Rifkin BS; Perazella MA
    Am J Med; 2004 Aug; 117(4):282-4. PubMed ID: 15308442
    [No Abstract]   [Full Text] [Related]  

  • 8. Tenofovir-induced nephrotoxicity: myths and facts.
    Gupta A; Bugeja A; Kirpalani D
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):148-9. PubMed ID: 22237241
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse events experienced by three children taking tenofovir and didanosine in combination.
    Hawkins S; Ball C
    HIV Med; 2007 Sep; 8(6):411. PubMed ID: 17661851
    [No Abstract]   [Full Text] [Related]  

  • 10. Tenofovir-induced acute renal failure in an HIV patient with normal renal function.
    Krummel T; Parvez-Braun L; Frantzen L; Lalanne H; Marcellin L; Hannedouche T; Moulin B
    Nephrol Dial Transplant; 2005 Feb; 20(2):473-4. PubMed ID: 15673708
    [No Abstract]   [Full Text] [Related]  

  • 11. [First line therapy. Tenofovir DF/emtricitabine--the potent backbone].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():12-4. PubMed ID: 19024908
    [No Abstract]   [Full Text] [Related]  

  • 12. Tenofovir-associated kidney diseases and interactions between tenofovir and other antiretrovirals.
    Lanzafame M; Lattuada E; Rapagna F; Gottardi M; Vento S
    Clin Infect Dis; 2006 Jun; 42(11):1656-7; author reply 1658. PubMed ID: 16652329
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-associated nephropathy and drug-induced renal injury.
    Panda A
    MedGenMed; 2006 Jun; 8(2):69. PubMed ID: 16926808
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute renal failure after initiation of tenofovir disoproxil fumarate.
    Hynes P; Urbina A; McMeeking A; Barisoni L; Rabenou R
    Ren Fail; 2007; 29(8):1063-6. PubMed ID: 18067059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.
    Malik A; Abraham P; Malik N
    J Infect; 2005 Aug; 51(2):E61-5. PubMed ID: 16038754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome.
    Schaaf B; Aries SP; Kramme E; Steinhoff J; Dalhoff K
    Clin Infect Dis; 2003 Aug; 37(3):e41-3. PubMed ID: 12884188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study.
    Antoniou T; Raboud J; Chirhin S; Yoong D; Govan V; Gough K; Rachlis A; Loutfy M
    HIV Med; 2005 Jul; 6(4):284-90. PubMed ID: 16011534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases.
    Blaas S; Schneidewind A; Glück T; Salzberger B
    AIDS; 2006 Aug; 20(13):1786-7. PubMed ID: 16931948
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of drug interactions and monitoring in the prevention of tenofovir-associated kidney disease.
    Winston JA; Shepp DH
    Clin Infect Dis; 2006 Jun; 42(11):1657-8; author reply 1658. PubMed ID: 16652330
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
    Gérard L; Chazallon C; Taburet AM; Girard PM; Aboulker JP; Piketty C
    Antivir Ther; 2007; 12(1):31-9. PubMed ID: 17503745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.